Nova Patents
ATE475710T1

Compositions and uses for cancer therapy

Abstract

Compositions and methods for the therapy of cancer, such as ovarian cancer, are disclosed. Compositions may comprise one or more ovarian carcinoma proteins, immunogenic portions thereof, polynucleotides that encode such portions or antibodies or immune system cells specific for such proteins. Such compositions may be used, for example, for the prevention and treatment of diseases such as ovarian cancer. Methods are further provided for identifying tumor antigens that are secreted from ovarian carcinomas and/or other tumors.

Term

Term ended

Projected expiry passed 17 December 2019, 6.8 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

91 members in 25 offices

This recordMember, by publication datePriority claim15 more offices are in the list below

Priority claims5

Priority claims
DocumentOfficeKindDate
21568198United States of AmericaA
21600398United States of AmericaA
33893399United States of AmericaA
40487999United States of AmericaA
9930270United States of AmericaW

Members91

Family members, oldest first
DocumentOfficeKind
CA2354156A1CanadaA1
WO0036107A2World Intellectual Property Organization (WIPO)A2
AU2197800AAustraliaA
WO0036107A3World Intellectual Property Organization (WIPO)A3
NO20013002D0NorwayD0
NO20013002LNorwayL
EP1141290A2European Patent Office (EPO)A2
KR20010101242ARepublic of KoreaA
BR9916207ABrazilA
TR2001002507T2TürkiyeT2
TR200102507T2TürkiyeT2
CA2418391A1CanadaA1
WO0206317A2World Intellectual Property Organization (WIPO)A2
AU7697301AAustraliaA
CN1333830AChinaA
IL143633A0IsraelA0
IL143633D0IsraelD0
HU0104717A2HungaryA2
HUP0104717A2HungaryA2
MXPA01006110AMexicoA
TR2002000937T2TürkiyeT2
TR200200937T2TürkiyeT2
PL349322A1PolandA1
US2002119158A1United States of AmericaA1
JP2002532093AJapanA
HK1044021A1Hong Kong, ChinaA1
US6468546B1United States of AmericaB1
ZA200104510BSouth AfricaB
US6488931B1United States of AmericaB1
NO20030211D0NorwayD0
US6528253B1United States of AmericaB1
NO20030211LNorwayL
KR20030022293ARepublic of KoreaA
US2003091580A1United States of AmericaA1
US2003124140A1United States of AmericaA1
WO0206317A3World Intellectual Property Organization (WIPO)A3
IL153996A0IsraelA0
IL153996D0IsraelD0
US2003165504A1United States of AmericaA1
EP1349870A2European Patent Office (EPO)A2
HU0302532A2HungaryA2
HUP0302532A2HungaryA2
CZ2003440A3CzechiaA3
US6670463B1United States of AmericaB1
NZ512247ANew ZealandA
US6699664B1United States of AmericaB1
MXPA03000527AMexicoA
JP2004526406AJapanA
CN1529713AChinaA
PL366575A1PolandA1
US2005031634A1United States of AmericaA1
US6858710B2United States of AmericaB2
BR0112542ABrazilA
HU0104717A3HungaryA3
HUP0104717A3HungaryA3
US6962980B2United States of AmericaB2
US7202334B1United States of AmericaB1
AU2001276973B2AustraliaB2
AU2007202776A1AustraliaA1
NZ551214ANew ZealandA
KR100836516B1Republic of KoreaB1
KR20080068143ARepublic of KoreaA
CN101230100AChinaA
NZ550860ANew ZealandA
EP1349870B1European Patent Office (EPO)B1
AT410446TAustriaT
ATE410446T1AustriaT1
DE60136099D1GermanyD1
CN100439395CChinaC
PT1349870EPortugalE
DK1349870T3DenmarkT3
EP2022800A2European Patent Office (EPO)A2
EP2022800A3European Patent Office (EPO)A3
ES2315296T3SpainT3
PL201529B1PolandB1
NZ567750ANew ZealandA
KR100935092B1Republic of KoreaB1
EP1141290B1European Patent Office (EPO)B1
AT475710TAustriaT
ATE475710T1This recordAustriaT1
CN101816788AChinaA
DE69942637D1GermanyD1
NZ578927ANew ZealandA
ES2350041T3SpainT3
US7888477B2United States of AmericaB2
AU2007202776B2AustraliaB2
US2011177082A1United States of AmericaA1
JP4942906B2JapanB2
IL143633AIsraelA
CZ303339B6CzechiaB6
CY1108790T1CyprusT1